HER2 expression in upper tract urothelial carcinoma and the relationship with clinicopathological characteristics—an analysis of 155 patients in Southwest China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2 expression in upper tract urothelial carcinoma and the relationship with clinicopathological characteristics—an analysis of 155 patients in Southwest China

Published:2024-09-13 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Ye Jianjun,Chen Zeyu,Liao Xinyang,Wang Xingyuan,Zhang Chichen,Han Ping,Wei Qiang,Bao Yige^ORCID

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-05222-8.pdf

Reference30 articles.

1. Rouprêt M et al (2021) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79(1):62–79

2. Seisen T et al (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052–1068

3. Suriano F, Brancato T (2014) Nephron-sparing management of upper tract urothelial carcinoma. Reviews In Urology 16(1):21–28

4. Scholl S, Beuzeboc P, Pouillart P (2001) Targeting HER2 in other tumor types. Ann Oncol 12(Suppl 1):S81–S87

5. Scherrer E et al (2022) HER2 expression in urothelial carcinoma, a systematic literature review. Front Oncol 12:1011885

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP